San Francisco, CA3 Active Studies

Retinitis Pigmentosa Clinical Trials in San Francisco, CA

Find 3 actively recruiting retinitis pigmentosa clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
532
Enrolling

Recruiting Retinitis Pigmentosa Studies in San Francisco

About Retinitis Pigmentosa Clinical Trials in San Francisco

Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.

There are currently 3 retinitis pigmentosa clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 532 participants. Research is being sponsored by Mitsubishi Tanabe Pharma America Inc., Disc Medicine, Inc, Laboratoires Thea. Clinical trial participation is free and participants receive study-related medical care at no cost.

Retinitis Pigmentosa Clinical Trials in San Francisco — FAQ

Are there retinitis pigmentosa clinical trials in San Francisco?

Yes, there are 3 retinitis pigmentosa clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What retinitis pigmentosa treatments are being tested?

The 3 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.

Data updated March 2, 2026 from ClinicalTrials.gov